תאריך: 31/12/2013
KEY POINTS
- The thalassemia syndromes are a heterogeneous group of disorders characterized by variable degrees of hemolysis, chronic anemia, and ineffective erythropoiesis.
- Because more patients are living longer, disease- and treatment-related complications are becoming more common.
- Optimal and safe transfusion support, iron chelation, noninvasive iron assessments, and stem cell therapies provide new tools for effective management of thalassemia.
Pediatr Clin N Am 60 (2013) 1383–1391 https://dx.doi.org/10.1016/j.pcl.2013.08.008
